Carmignac Gestion Bio N Tech Se Transaction History
Carmignac Gestion
- $6.18 Billion
- Q4 2024
A detailed history of Carmignac Gestion transactions in Bio N Tech Se stock. As of the latest transaction made, Carmignac Gestion holds 222,095 shares of BNTX stock, worth $22.4 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
222,095
Previous 187,670
18.34%
Holding current value
$22.4 Million
Previous $22.3 Million
13.54%
% of portfolio
0.41%
Previous 0.38%
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
364Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$829 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$444 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$433 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$191 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$182 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...